Global law firm Baker McKenzie advised Bristol Myers Squibb (BMS) on the sale of its manufacturing facility in East Syracuse, New York to LOTTE. The East Syracuse site will serve as the LOTTE Center for North America Operations for LOTTE’s new biologics contract development and manufacturing organization (CDMO) business in the US.

The companies anticipate completing the transaction by the second half of 2022, subject to receipt of regulatory approvals and the satisfaction of other closing conditions. Upon closing, LOTTE will acquire the East Syracuse site’s operations and assets, which include the property, plant and equipment, as well as a workforce. LOTTE, under a newly-established CDMO relationship, will manufacture product for Bristol Myers Squibb from the East Syracuse facility. Read the full release here.

The Baker McKenzie team that advised BMS was led by Olivia Tyrrell, supported by a team including Michelle Carr, Airi Hammalov, Anat Polyachenko, Jessica Wicha, Sarah Winston, Victor Flores, Teisha Johnson and Adam Aft.

Baker McKenzie is a transactional powerhouse, with more than 2,500 deal lawyers in over 46 countries offering leading expertise in the areas most critical for our clients. We excel in complex transactions and cross-border deals – over 60% of our deals are multi-jurisdictional. We are global and local, combining money-market sophistication with local excellence. In 2021 alone, the US Transactions Team handled 15 multi-billion dollar mergers and acquisitions. The Firm's Life Sciences team includes 800 dedicated Healthcare & Life Sciences lawyers worldwide, bringing our vast industry transactional experience to work for our clients, in addition to collaborating with our IP and regulatory colleagues around the world.
Explore Our Newsroom